$SNEX

Maurer Mark Lowry sold $3.9M of SNEX

Maurer Mark Lowry sold 52,376 shares of StoneX Group Inc. (SNEX) at $74.32 ($3.89M total) on 2026-07-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Maurer Mark Lowry
Published Jul 24, 2026, 12:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
medium confidence
Mentioned
$SNEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The newest fact is the specific sale size, price, and post-transaction holdings, but the 10b5-1 designation suggests limited informational content.

02

Market read

Primarily useful for monitoring insider activity and potential sentiment, not for a fundamental re-rating.

03

What to watch

Traders may want to compare this sale size and cadence versus prior Form 4 activity to judge whether it is truly routine.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-23, covering a sale executed 2026-07-22.

Background

The article is an SEC Form 4 insider transaction disclosure for StoneX Group Inc.

Company-level read

Ticker impact

$SNEXNeutralMedium confidence
Context

StoneX Group insider Maurer Mark Lowry filed a Form 4 open-market sale of 52,376 shares at $74.3218 on 2026-07-22 under a 10b5-1 plan.

Expected impact

Limited immediate impact; any effect is likely short-lived unless follow-on filings show unusual acceleration or size.

Evidence & confidence

The filing is a disclosed open-market sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector read-across; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • StoneX Group Inc.

    Company whose insider transaction was disclosed on SEC Form 4.

  • Maurer Mark Lowry

    Reporter of the Form 4 open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.